Literature DB >> 5417793

Chemotherapy of malignant melanoma.

G Westbury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5417793      PMCID: PMC1810924     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  9 in total

1.  INTRA-ARTERIAL ADMINISTRATION OF 2-ETHYLHYDRAZIDE OF PODOPHYLLIC ACID (NSC-72274) IN LOCALIZED MALIGNANT DISEASE.

Authors:  K A NEWTON; G WESTBURY; W F WHITE
Journal:  Cancer Chemother Rep       Date:  1964-12

2.  MELANOMA OF THE EXTREMITIES; EXPERIENCES WITH CONVENTIONAL TREATMENT AND PERFUSION IN 339 CASES.

Authors:  J S STEHLIN; R L CLARK
Journal:  Am J Surg       Date:  1965-09       Impact factor: 2.565

3.  Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.

Authors:  G WESTBURY; J G HUMBLE; K A NEWTON; M E SKINNER; D E PEGG
Journal:  Lancet       Date:  1959-05-09       Impact factor: 79.321

4.  Radiotherapy of malignant melanomata of the eye.

Authors:  M LEDERMAN
Journal:  Br J Radiol       Date:  1961-01       Impact factor: 3.039

5.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

6.  Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report.

Authors:  C T KLOPP; T C ALFORD; J BATEMAN; G N BERRY; T WINSHIP
Journal:  Ann Surg       Date:  1950-10       Impact factor: 12.969

7.  A study of 650 observed malignant melanomas in the South-West region.

Authors:  D C Bodenham
Journal:  Ann R Coll Surg Engl       Date:  1968-10       Impact factor: 1.891

8.  Melanoma of the nervous system: treatment with corticosteroids and radiation.

Authors:  H R Beresford
Journal:  Neurology       Date:  1968-03       Impact factor: 9.910

9.  Treatment of disseminated melanoma by systemic melphalan, methotrexate and autogenous bone marrow transplants. Experience with 114 patients.

Authors:  I M Ariel; G T Pack
Journal:  Cancer       Date:  1967-01       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.